The molecular biology of ependymomas

Brain Pathology

Volumn 7, Issue 2, 1997, Pages 807-822

  Hamilton, Ronald L ^a,b   Pollack, Ian F ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; CHILD; CHILDHOOD CANCER; CHROMOSOME 17P; CHROMOSOME 22; CONFERENCE PAPER; EPENDYMOMA; HUMAN; HUMAN TISSUE; TUMOR SUPPRESSOR GENE;

EID: 0030999539     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1997.tb01066.x     Document Type: Conference Paper

References (177)

1. Afra D, Muller W, Slowik F, Wilcke O, Budka H, Turoczy L (1983) Supratentonal lobar ependymomas. reports on the grading and survival periods in 80 cases, including 46 recurrences Acta Neurochir 69: 243-251
2. Antoniades HN, Galanopoulos T, Neville-Golden J, Maxwell M (1992) Expression of insulin-like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas: in vivo studies using in situ hybridization and immunocytochemistry. Int J Cancer 50: 215-222
3. Arnoldus EP, Welters LB, Voormolen JH, van Duinen SG, Raap AK, van der Ploeg M, Peters AC (1992) Interphase cytogenetics a new tool for the study of genetic changes in brain tumors. J Neurosurg 76: 997-1003
4. Asai A, Hoshino T, Edwards MS, Davis RL (1992) Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index. Childs Nerv Syst 8 273-278
5. Awaad YM, Allen JC, Miller DC, Schneider SJ, Wisoff J, Epstein FJ (1996) Deferring adjuvant therapy for totally resected intracranial ependymoma. Fed Neurol 14: 216-219
6. Barone BM, Elvidge AR (1970) Ependymomas. A clinical survey. J Neurosurg 33: 428-438
7. Becker I, Becker KF, Meyermann R, Hollt V (1991) The multidrug-resistance gene MDR1 is expressed in human glial tumors. Acta Neuropathol 82: 516-519
8. Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL (1992) DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Eng J Med 326: 988-993
9. Bigner SH, Wong AJ, Mark J, Muhlbaier LH, Kinzler KW, Vogelstein B, Bigner DD (1987) Relationship between gene amplification and chromosomal deviations in malignant human gliomas. Cancer Genet Cytogenet 29: 165-170
10. Bijlsma EK, Voesten AM, Bijleveld EH, Troost D, Westerveld A, Merel P, Thomas G, Hulsebos TJ (1995) Molecular analysis of genetic changes in ependymomas. Genes Chromosom Cancer 13: 272-277
11. Bloom HJ, Glees J, Bell J, Ashley SE, Gorman C (1990) The treatment and long-term prognosis of children with intracranial tumors, a study of 610 cases, 1950-1981. Int J Radiat Oncol Biol Phys 18: 723-745
12. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224: 1121-1124
13. Burger P, Scheithauer B (1994) Tumors of the central nervous system Atlas of tumor pathology 3rd series. Fascicle 10, Armed Forces Institute of Pathology: Washington DC
14. Chiu JK, Woo SY, Ater J, Connelly J, Bruner JM, Maor MH, van Eys J, Oswald MJ, Shallenberger R (1992) Intracranial ependymoma in children: analysis of prognostic factors. J Neuro-onc 13: 283-290
15. Chou PM, Barquin N, Gonzalezcrussi F, Sanz CR, Tomita T, Reyesmugica M (1996) Ependymomas in children express the multidrug resistance gene immunohistochemical and molecular biologic study. Ped Pathol Lab Med 16: 551-561
16. Cogen PH (1991) Prognostic significance of molecular genetic markers in childhood brain tumors. Ped Neurosurg 17: 245-250
17. Cogen PH, Daneshvar L, Metzger AK, Duyk G, Edwards MS, Sheffield VC (1992) Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am J Med Genet 50 584-589
18. Collins VP, James CD (1993) Gene and chromosomal alterations associated with the development of human gliomas. FASEB J 7 926-930
19. Corallini A, Pagnani M, Viadana P, Silini E, Mottes M, Milanesi G, Gerna G, Vetter R, Trapella G, Silvani V, et al. (1987) Association of BK virus with human brain tumors and tumors of pancreatic islets. Int J Cancer 39: 60-67
20. Coulon RA, Till K (1977) Intracranial ependymomas in children a review of 43 cases. Childs Brain 3: 154-168
21. Dal Cin P, Sandberg AA (1988) Cytogenetic findings in a supratentorial ependymoma. Cancer Genet Cytogenet 30: 289-293
22. Debiec-Rychter M, Lasota J, Alwasiak J, Liberski PP (1995) Recurrent anaplastic ependymoma with an abnormal karyotype and c-myc proto-oncogene overexpression. Acta Neuropathol 89: 270-274
23. DeMonte F, AI-Mefty O (1995) Meningiomas. In: Brain Tumors, Kaye A, Laws Jr. E (eds.), pp. 675-704, Churchill Livingstone: New York, NY
24. Diedrich U, Eckermann O, Schmidtke J (1988) Rare Haras and c-mos alleles in patients with intracranial tumors. Neurology 38 587-589
25. Diedrich U, Soja S, Behnke J, Zoll B (1991) Amplification of the c-erbB oncogene is associated with malignancy in primary tumours of neuroepithelial tissue. J Neurol 238: 221-224
26. Dohrmann GJ, Farwell JR, Flannery JT (1976) Ependymomas and ependymoblastomas in children. J Neurosurg 45: 273-283
27. Duffner P, Cohen M, Voorhess M, MacGillivray M, Brecher M, Panahon A, Gilani B (1985) Long-term effects of cranial irradiation on endocrine function m children with brain tumors: a prospective study. Cancer 56: 2189-2193
28. Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE, Freeman CR, et al. (1993) Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Eng J Med 328: 1725-1731
29. Dumanski JP, Rouleau GA, Nordenskjold M, Collins VP (1990) Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res 50: 5863-5867
30. Egelhoff JC, Bates DJ, Ross JS, Rothner AD, Cohen BH (1992) Spinal MR findings in neurofibromatosis types 1 and 2. Am J Neuradiol 13 1071-1077
31. Ekstrand AJ, James CD, Cavenee WK, Seliger B, Pettersson RF, Collins VP (1991) Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo Cancer Res 51: 2164-2172
32. Ellenberg L, McComb J, Siegel S, Stowe S (1987) Factors affecting intellectual outcome in pediatric brain tumor patients Neurosurg 21 638-644
33. Ernestus RI, Schroder R, Stutzer H, Klug N (1996) Prognostic relevance of localization and grading in intracranial ependymomas of childhood Childs Nerv Syst 12 522-526
34. Ernestus RI, Wilcke O, Schroder R (1989) Intracranial ependymomas: prognostic aspects. Neurosurg Rev 12: 157-163
35. Ernestus RI, Wilcke O, Schroder R (1991) Supratentonal ependymomas in childhood: clinicopathological findings and prognosis. Acta Neurochir 111: 96-102
36. Evans AE, Anderson JR, Lefkowitz-Boudreaux IB, Finlay JL (1996) Adjuvant chemotherapy of childhood posterior fossa ependymoma cranio-spinal irradiation with or without adjuvant CCNU. vincristine, and prednisone: a Childrens Cancer Group study. Med Pediatr Oncol 27: 8-14
37. Ferrante L, Mastronardi L, Schettini G, Lunardi P, Fortuna A (1994) Fourth ventricle ependymomas. A study of 20 cases with survival analysis. Acta Neurochir 131: 67-74
38. Figarella-Branger D, Gambarelli D, Dollo C, Devictor B, Perez-Castillo AM, Genitori L, Lena G, Choux M, Pellissier JF (1991) Infratentorial ependymomas of childhood. Correlation between histological features, immunohistological phenotype, silver nucleolar organizer region staining values and post-operative survival in 16 cases Acta Neuropathol 82: 208-216
39. Figarella-Branger D, Lepidi H, Poncet C, Gambarelli D, Bianco N, Rougon G, Pellissier JF (1995) Differential expression of cell adhesion molecules (CAM), neural CAM and epithelial cadherin in ependymomas and choroid plexus tumors. Acta Neuropathol 89: 248-257
40. Fink KL, Rushing EJ, Schold SC, Jr., Nisen PD (1996) Infrequency of p53 gene mutations in ependymomas. J Neuro-Oncol 27: 111-115
41. Friedman HS, Krischer JP, Burger P, Oakes WJ, Hockenberger B, Weiner MD, Falletta JM, Morris D, Ragab AH, Mahoney DH, Jr., et al. (1992) Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study. J Clin Oncol 10: 249-256
42. Fujimoto M, Sheridan PJ, Sharp ZD, Weaker FJ, Kagan-Hallet S, Story JL (1989) Proto-oncogene analyses in brain tumors J Neurosurg 70: 910-915
43. Fujimoto M, Weaker FJ, Herbert DC, Sharp ZD, Sheridan PJ, Story JL (1988) Expression of three viral oncogenes (v-sis, v-myc, v-fos) in primary human brain tumors of neuroectodermal origin. Neurology 38: 289-293
44. Fuller GN, Bigner SH (1992) Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutation Res 276: 299-306
45. Gammeltoft S, Ballotti R, Kowalski A, Westermark B, Van Obberghen E (1988) Expression of two types of receptor for insulin-like growth factors in human malignant glioma. Cancer Res 48: 1233-1237
46. Garson JA, McIntyre PG, Kemshead JT (1985) N-myc amplification in malignant astrocytoma. Lancet 2: 718-719
47. Geddes JF, Vowles GH, Ashmore SM, Cockburn HA, Darling JL (1994) Detection of multidrug resistance gene product (P-gtycoprotein) expression in ependymomas. Neuropathol App Neurobiol 20: 118-121
48. Gerszten PC, Pollack IF, Martinez AJ, Lo KH, Janosky J, Albright AL (1996) Intracranial ependymomas of childhood-lack of correlation of histopathology and clinical outcome. Pathol Res Prac 192: 515-522
49. Geyer JR, Zeltzer PM, Boyett JM, Rorke LB, Stanley P, Albright AL, Wisoff JH, Milstein JM, Allen JC, Finlay JL, et al (1994) Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group. J Clin One 12: 1607-1615
50. Gilles FH, Sobel EL, Tavare CJ, Leviton A, Hedley-Whyte ET (1995) Age-related changes in diagnoses, histological features, and survival in children with brain tumors: 1930-1979. The Childhood Brain Tumor Consortium. Neurosurgery 37: 1056-1068
51. Goldwein JW, Glauser TA, Packer RJ, Finlay JL, Sutton LN, Curran WJ, Laehy JM, Rorke LB, Schut L, D'Angio GJ (1990) Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors. Cancer 66 557-563
52. Greenlee JE, Seeker LE, Narayan O, Johnson RT (1978) Failure to demonstrate papovavirus tumor antigen in human cerebral neoplasms. Ann Neurol 3: 479-481
53. Griffin CA, Long PR Carson BS, Brem H (1992) Chromosome abnormalities in low-grade central nervous system tumors. Cancer Genet Cytognet 60: 67-73
54. Guha A (1991) Platelet-derived growth factor: a general review with emphasis on astrocytomas. Pediatr Neurosurg 17: 14-20
55. Hall WA, Merrill MJ, Walbridge S, Youle RJ (1990) Epidermal growth factor receptors on ependymomas and other brain tumors. J Neurosurg 72: 641-646
56. Healey EA, Barnes PD, Kupsky WJ, Scott RM, Sallan SE, Black PM, Tarbell NJ (1991) The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery 28: 666-671; discussion 671-662
57. Hoang-Xuan K, Merel P, Vega F, Hugot JP, Cornu P, Delattre JY, Poisson M, Thomas G, Delattre O (1995) Analysis of the NF2 tumor-suppressor gene and of chromosome 22 deletions in gliomas. Int J Cancer 60: 478-481
58. Hoshino T (1984) A commentary on the biology and growth kinetics of low-grade and high-grade gliomas. J Neurosurg 61: 895-900
59. Ikezaki K, Matsushima T, Inoue T, Yokoyama N, Kaneko Y, Fukui M (1993) Correlation of microanatomical localization with postoperative survival in posterior fossa ependymomas. Neurosurgery 32: 38-44
60. James CD, Carlbom E, Dumanski JP, Hansen M, Nordenskjold M, Collins VR Cavenee WK (1988) Clonal genomic alterations in glioma malignancy stages. Cancer Res 48: 5546-5551
61. James CD, He J, Carlbom E, Mikkelsen T, Ridderheim PA, Cavenee WK, Collins VP (1990) Loss of genetic information in central nervous system tumors common to children and young adults. Genes Chromos Cancer 2: 94-102
62. James CD, Mikkelsen T, Cavenee WK, Collins VP (1990) Molecular genetic aspects of glial tumour evolution. Cancer Surveys 9 631-644
63. Jayawickreme DP, Hayward RD, Harkness WF (1995) Intracranial ependymomas in childhood: a report of 24 cases followed for 5 years. Childs Nerv Syst 11: 409-413
64. Jenkins RB, Kimmel DW, Moertel CA, Schultz CG, Scheithauer BW, Kelly PJ, Dewald GW (1989) A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet 39: 253-279
65. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T (1994) Ki-67 immunoreactivity in human central nervous system tumors a study with MIB 1 monoclonal antibody on archival material. Acta Neuropathol 87: 47-54
66. Karga HJ, Alexander JM, Hedley-Whyte ET, Klibanski A, Jameson JL (1992) Ras mutations in human pituitary tumors. J Clin Endocrinol Metab 74: 914-919
67. Karlbom AE, James CD, Boethius J, Cavenee WK, Collins VR Nordenskjold M, Larsson C (1993) Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Human Genetics 92: 169-174
68. Kernohan J, Sayre G (1952) Tumors of the central nervous system. Atlas of tumor pathology, Section X, Fascicles 35 and 37, Armed Forces Institute of Pathology Washington DC
69. Khalid H, Yasunaga A, Kishikawa M, Shibata S (1995) Immunohistochemical expression of the estrogen receptor-related antigen (ER-D5) in human intracranial tumors Cancer 75: 2571-2578
70. King P, Cooper PN, Malcolm AJ (1993) Soft tissue ependymoma: a report of three cases. Histopathology 22: 394-396
71. Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O'Brien SJ, Wong AJ, Vogelstein B (1987) Identification of an amplified, highly expressed gene in a human glioma. Science 236: 70-73
72. Kirschstein R, Gerber P (1962) Ependymomas produced after intracerebral innoculation of SV40 into new-born hamsters. Nature 195: 299-300
73. Kleihues P, Burger P, Scheithauer B (1993) The new WHO classification of brain tumors. Brain Pathol 3 255-268
74. Kordek R, Hironishi M, Liberski PP, Yanagihara R, Gajdusek DC U (1996) Apoptosis in glial tumors as determined by in situ nonradioactive labeling of DNA breaks. Acta Neuropathol 91: 112-116
75. Kosaka H, Sano Y, Matsukado Y, Satrenji T, Hinuma Y (1980) Failure to detect papovavirus-associated T antigens in human brain tumor cells by anticomplement immunofluorescence. J Neurosurg 52: 367-370
76. Kovalic JJ, Flans N, Grigsby PW, Pirkowski M, Simpson JR, Roth KA (1993) Intracranial ependymoma long-term outcome, patterns of failure. J Neuro-Onc 15: 125-131
77. Krainer M, Schenk T, Zielinski CC, Muller C (1995) Failure to confirm presence of SV40 sequences in human tumours. Eur J Cancer 31A: 1893
78. Krontiris TG, DiMartino NA, Colb M, Parkinson DR (1985) Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients. Nature 313: 369-374
79. Kum W, Cockram CS, Zhu SQ, Teoh R, Young JD (1989) Insulin binding to human astrocytoma cells and its effect on uridine incorporation into nucleic acid J Neurochem 52: 242-247
80. Landis CA, Harsh G, Lyons J, Davis RL, McCormick F, Bourne HR (1990) Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein. J Clin Endocrinol Metab 71: 1416-1420
81. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L (1989) GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours Nature 340: 692-696
82. Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW, Vogelstein B (1993) p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 53 2231-2234
83. Lednicky JA, Garcea RL, Bergsagel DJ, Butel JS (1995) Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology 212 710-717
84. Lee M, Rezai AR, Freed D, Epstein FJ (1996) Intramedullary spinal cord tumors in neurofibromatosis. Neurosurgery 38: 32-37
85. Louis D, Ramesh V, Gusella J (1995) Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors. Brain Pathol 5: 163-172
86. Lyons MK, Kelly PJ (1991) Posterior fossa ependymomas report of 30 cases and review of the literature. Neurosurgery 28: 659-664
87. Matsumoto T, Tani E, Kaba K, Shindo H, Miyaji K (1991) Expression of P-glycoprotein in human glioma cell lines and surgical glioma specimens. J Neurosurg 74 460-466
88. Meinke W, Goldstein DA, Smith RA (1979) Simian virus 40-related DNA sequences in a human brain tumor Neurology 29: 1590-1594
89. Metzger AK, Sheffield VC, Duyk G, Daneshvar L, Edwards MS, Cogen PH (1991) Identification of a germline mutation in the p53 gene in a patient with an intracranial ependymoma Proc Natl Acad Sci USA 88 7825-7829
90. Mikkelsen T, Cairncross JG, Cavenee WK (1991) Genetics of the malignant progression of astrocytoma J Cell Biochem 46: 3-8
91. Milner J, Medcalf E (1991) Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell 65: 765-774
92. Mineurs K, Izumi I, Kuwahara N, Kowada M (1994) O6-methylguanme-DNA methyltransferase activity in cerebral gliomas. A guidance for nitrosourea treatment? Acta Oncologies 33: 29-32
93. Mork SJ, token AC (1977) Ependymoma: a follow-up study of 101 cases. Cancer 40: 907-915
94. Muller HL, Oh Y, Gargosky SE, Lehrnbecher T, Hintz RL, Rosenfeld RG (1993) Concentrations of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3), IGF, and IGFBP-3 protease activity in cerebrospinal fluid of children with leukemia, central nervous system tumor, or meningitis. J Clin Endocrinol Metab 77: 1113-1119
95. Nabors MW, Griffin CA, Zehnbauer BA, Hruban RH, Phillips PC, Grossman SA, Brem H, Colvin OM (1991) Multidrug resistance gene (MDR1) expression in human brain tumors. J Neurosurg 75: 941-946
96. Nagashima T, Hoshino T, Cho KG, Edwards MS, Hudgins RJ, Davis RL (1988) The proliferative potential of human ependymomas measured by in situ faromodeoxyundine labeling. Cancer 61 2433-2438
97. Nazar GB, Hoffman HJ, Becker LE, Jenkin D, Humphreys RP, Hendrick EB (1990) Infratentorial ependymomas in childhood prognostic factors and treatment J Neurosurg 72: 408-417
98. Neumann E, Kalousek DK, Norman MG, Steinbok P, Cochrane DD, Goddard K (1993) Cytogenetic analysis of 109 pediatric central nervous system tumors. Cancer Genet Cytogenet 71: 40-49
99. Newcomb EW, Madonia WJ, Pisharody S, Lang FF, Koslow M, Miller DC (1993) A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathol 3: 229-235
100. Nijssen PC, Deprez RH, Tijssen CC, Hagemeijer A, Arnoldus EP, Teepen JL, Holl R, Niermeyer MF (1994) Familial anaplastic ependymoma. evidence of loss of chromosome 22 in tumour cells J Neurol Neurosurg Psychiat 57 1245-1248
101. Nister M, Libermann TA, Betsholtz C, Pettersson M, Claesson-Welsh L, Heldin CH, Schlessinger J, Westermark B (1988) Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. Cancer Res 48: 3910-3918
102. Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P (1991) p53 mutations in nonastrocytic human brain tumors. Cancer Res 51: 6202-6205
103. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas Nature 358: 80-83
104. Palma L, Celli P, Cantore G (1993) Supratentorial ependymomas of the first two decades of life. Long-term follow-up of 20 cases (including two subependymomas). Neurosurgery 32: 169-175
105. Paoletti P, Butti G, Zibera C, Scerrati M, Gibelli N, Roselli R, Magrassi L, Sica G, Rossi G, Robustelli della Cuna G (1990) Characteristics and biological role of steroid hormone receptors in neuroeprthelial tumors. J Neurosurg 73: 736-742
106. Papadopoulos DP, Gin S, Evans RG (1990) Prognostic factors and management of intracranial ependymomas. Anticancer Res 10: 689-692
107. Park JR, Chaffee S, Noll WW, Rhodes CH (1996) Constitutional de novo t(1,22)(p22,q11.2) and ependymoma Cancer Genet Cytogener 86 150-152
108. Paulus W, Grothe C, Sensenbrenner M, Janet T, Baur I, Graf M, Roggendorf W (1990) Localization of basic fibroblast growth factor, a mitogen and angiogenic factor. in human brain tumors. Acta Neuropathol 79 418-423
109. Pershouse MA, Stubblefield E, Hadi A, Killary AM, Yung WK, Steck PA (1993) Analysis of the functional role of chromosome 10 loss in human ghoblastomas Cancer Res 53: 5043-5050
110. Pollack IF (1994) Brain tumors in children N Engl J Med 331: 1500-1507
111. Pollack IF, Gerszten PC, Martinez AJ, Lo KH, Shultz B, Albright AL, Janosky J, Deutsch M (1995) Intracranial ependymomas of childhood: long-term outcome and prognostic factors Neurosurgery 37: 655-666
112. Raffel C (1996) Molecular biology of pediatric gliomas. J Neuro-Oncol 28 121-128
113. Ransom DT, Ritland SR, Kimmel DW, Moertel CA, Dahl RJ, Scheithauer BW, Kelly PJ, Jenkins RB (1992) Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas. Genes Chromos Cancer 5 348-356
114. Rasheed BK, Bigner SH (1991) Genetic alterations in glioma and medulloblastoma. Cancer Metast Rev 10: 289-299
115. Read G (1984) The treatment of ependymoma of the brain or spinal canal by radiotherapy a report of 79 cases. Clin Radiol 35: 183-166
116. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP (1993) Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53: 2736-2739
117. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP (1994) Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2 Cancer Res 54: 4299-4303
118. Rey JA, Bello MJ, de Campos JM, Kusak ME, Moreno S (1987) Chromosomal composition of a series of 22 human low-grade gliomas. Cancer Genet Cytogenet 29: 223-237
119. Reyes-Mugica M, Chou PM, Myint MM, Ridaura-Sanz C, Gonzalez-Crussi F, Tomita T (1994) Ependymomas in children, histologic and DNA-flow cytometric study. Pediatr Pathol 14 453-466
120. Rezai A, Woo HH, Lee M, Cohen H, Zagzag D, Epstein FJ (1996) Disseminated ependymomas of the central nervous system. J Neurosurg 85: 618-624
121. Rogatto SR, Casartelli C, Rainho CA, Barbieri-Neto J (1993) Chromosomes in the genesis and progression of ependymomas. Cancer Genet Cytogenet 69 146-152
122. Romic Stojkovic R, Jovancevic M, Santel DJ, Grcevic N, Gamulin S (1990) Sex steroid receptors in intracranial tumors. Cancer 65: 1968-1970
123. Rorke L, Gilles F, Davis R, Becker L (1985) Revision of the World Health Organization classification of brain tumors. Cancer 56: 1869-1886
124. Rorke LB (1987) Relationship of morphology of ependymoma in children to prognosis. Prog Exp Tumor Res 30: 170-174
125. Ross GW, Rubinstein LJ (1989) Lack of histopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg 70: 31-36
126. Rouleau G, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang X, Demczuk S, Desmaze C, Plougastel B, Pulst S, Lenoir G, Biljsma E, Fashold R, Dumanski J, de Jong P, Parry D, Eldridge R, Aurias A, Delattre O (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 363: 515-521
127. Rousseau P, Habrand JL, Sarrazin D, Kalifa C, Terrier-Lacombe MJ, Rekacewicz C, Rey A (1994) Treatment of intracramal ependymomas of children: review of a 15-year experience. Int J Radiat Oncol Biol Phys 28: 381-386
128. Rubinstein L (1972) Tumors of the central nervous system. Atlas of tumor pathology, 2nd series, Fascicle 6, Armed Forces Institute of Pathology: Washington DC
129. Rubio MP, Correa KM, Ramesh V, MacCollin MM, Jacoby LB, von Deimling A, Gusella JF, Louis DN (1994) Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas Cancer Res 54: 45-47
130. Rubio MP, von Deimling A, Yandell DW, Wiestler OD, Gusella JF, Louis DN (1993) Accumulation of wild-type p53 protein in human astrocytomas. Cancer Res 53: 3465-3467
131. Sainati L, Montaldi A, Putti MC, Giangaspero F, Rigobello L, Stella M, Zanesco L, Basso G (1992) Cytogenetic t(11;17)(q13;q21) in a pediatric ependymoma. Is 11q13 a recurring breakpoint in ependymomas? Cancer Genet Cytogenet 59: 213-216
132. Salazar OM, Rubin P, Bassano D, Marcial VA (1975) Improved survival of patients with intracranial ependymomas by irradiation: dose selection and field extension. Cancer 35: 1563-1573
133. Salgaller M, Agius L, Yates A, Pearl D, Roberts W, Stephens R (1990) Application of automated image analysis to demonstrate the correlation between ras p21 expression and severity of gliomas Biochem Biophysic Res Com 169: 482-491
134. Salgaller M, Pearl D, Stephens R (1991) In situ hybridization with single-stranded RNA probes to demonstrate infrequently elevated gli mRNA and no increased ras mRNA levels in meningiomas and astrocytomas. Cancer Letters 57-243-253
135. Samuels V, Barrett JM, Bockman S, Pantazis CG, Allen MB, Jr. (1989) Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas. Am J Pathol 134: 894-902
136. Sato T, Shimoda A, Takahashi T, Kurokawa H, Ando M, Goto S, Takamura H (1984) Congenital anaplastic ependymoma: a case report of familial glioma. Childs Brain 11-342-348
137. Savard ML, Gilchrist DM (1989) Ependymomas in two sisters and a maternal male cousin with mosaicism with monosomy 22 in tumour Pediatr Neurosci 15: 80-84
138. Sawyer JR, Sammartino G, Husain M, Boop FA, Chadduck WM (1994) Chromosome aberrations in four ependymomas. Cancer Genet Cytogenet 74: 132-138
139. Saxena A, Clark WC, Robertson JT, Ikejin B, Oldfield EH, Ali IU (1992) Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Cancer Res 52: 6716-6721
140. Scheurlen WG, Senf L (1995) Analysis of the GAP-related domain of the neurofibromatosis type 1 (NF1) gene in childhood brain tumors Int J Cancer 64: 234-238
141. Schiffer D, Chio A, Cravioto H, Giordana MT, Migheli A, Soffietti R, Vigliani MC (1991) Ependymoma: internal correlations among pathological signs: the anaplastic variant. Neurosurgery 29: 206-210
142. Schiffer D, Chio A, Giordana MT, Migheli A, Palma L, Polio B, Soffietti R, Tribolo A (1991) Histologic prognostic factors in ependymoma. Childs Nerv Syst 7: 177-182
143. Schroder R, Ploner C, Ernestus RI (1993) The growth potential of ependymomas with varying grades of malignancy measured by the Ki-67 labelling index and mitotic index. Neurosurg Rev 16: 145-150
144. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313: 1111-1116
145. Shaw EG, Evans RG, Scheithauer BW, Ilstrup DM, Earle JD (1987) Postoperative radiotherapy of intracramal ependymoma in pediatric and adult patients. Int J Radiat Oncol Biol Phys 13: 1457-1462
146. Shuman RM, Alvord EC, Jr., Leech RW (1975) The biology of childhood ependymomas. Arch Neurol 32: 731-739
147. Sieb JP, Pulst SM, Buch A (1992) Familial CNS tumors. J Neurol 239: 343-344
148. Silber JR, Mueller BA, Ewers TG, Berger MS (1993) Comparison of O6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain. Cancer Res 53: 3416-3420
149. Slave I, MacCollin MM, Dunn M, Jones S, Sutton L, Gusella JF, Siegel JA (1995) Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas. Int J Cancer 64: 243-247
150. Steck PA, Ligon AH, Cheong P, Yung WK, Pershouse MA (1995) Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromos Cancer 12: 255-261
151. Steinbok P, Hentschel S, Cochrane DD, Kestle JR (1996) Value of postoperative surveillance imaging in the management of children with some common brain tumors. J Neurosurg 84: 726-732
152. Stratton MR, Darling J, Lantos PL, Cooper CS, Reeves BR (1989) Cytogenetic abnormalities in human ependymomas. Int J Cancer 44: 579-581
153. Sutton LN, Goldwein J, Perilongo G, Lang B, Schut L, Rorke L, Packer R (1990) Prognostic factors in childhood ependymomas Pediatr Neurosurg 16: 57-65
154. Thapar K, Fukuyama K, Rutka J (1995) Neurogenetics and the molecular biology of human brain tumors In: Brain Tumors. Kaye A, Laws Jr E (eds.), pp. 69-97, Churchill Livingstone: New York, NY
155. Thiel G, Marczinek K, Neumann R, Witkowski R, Marchuk DA, Nurnberg P (1995) Somatic mutations in the neurofibromatosis 1 gene in gliomas and primitive neuroectodermal tumours. Anticancer Res 15: 2495-2499
156. Tominaga T, Kayama T, Kumabe T, Sonoda Y, Yoshimoto T (1995) Anaplastic ependymomas. clinical features and tumour suppressor gene p53 analysis. Acta Neurochir 135 163-170
157. Torp SH, Helseth E, Ryan L, Stolan S, Dalen A, Unsgaard G (1991) Amplification of the epidermal growth factor receptor gene in human gliomas. Anticancer Res 11: 2095-2098
158. Trent J, Meltzer P, Rosenblum M, Harsh G, Kinzler K, Mashal R, Feinberg A, Vogelstein B (1986) Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma Proc Natl Acad Sci USA 83: 470-473
159. Ueki K, Rubio MR Ramesh V, Correa KM, Rutter JL, von Deimling A, Buckler AJ, Gusella JF, Louis DN (1994) MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Hum Mol Genet 3: 1841-1845
160. Undjian S, Mannov M (1990) Intracranial ependymomas in children. Childs Nerv Syst 6: 131-134
161. Vagner-Capodano AM, Gentet JC, Gambarelli D, Pellissier JF, Gouzien M, Lena G, Geniton L, Choux M, Raybaud C (1992) Cytogenetic studies in 45 pediatric brain tumors. Pediatr Hematol Oncol 9: 223-235
162. Vanuytsel LJ, Bessell EM, Ashley SE, Bloom HJ, Brada M (1992) Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy. Int J Radiat Oncol Biol Phys 23: 313-319
163. von Schoultz E, Bixo M, Backstrom T, Silfvenius H, Wilking N, Hennksson R (1990) Sex steroids in human brain tumors and breast cancer. Cancer 65: 949-952
164. Vonhaken MS, White EC, Daneshvarshyesther L, Sih S, Choi E, Kalra R, Cogen PH (1996) Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic ependymomas. Genes Chromos Cancer 17: 37-44
165. Waha A, Baumann A, Wolf HK, Fimmers R, Neumann J, Kindermann D, Astrahantseff K, Blumcke I, Vondeimling A, Schlegel U (1996) Lack of prognostic relevance of alterations in the epidermal growth factor receptor transforming growth factor-alpha pathway in human astrocytic gliomas. J Neurosurg 85: 634-641
166. Wasson JC, Saylors RLd, Zeltzer P, Friedman HS, Bigner SH, Burger PC, Bigner DD, Look AT, Douglass EC, Brodeur GM (1990) Oncogene amplification in pediatric brain tumors Cancer Res 50: 2987-2990
167. Weitman SD, Frazier KM, Kamen BA (1994) The folate receptor in central nervous system malignancies of childhood. J Neuro-Oncol 21: 107-112
168. Weremowicz S, Kupsky WJ, Morton CC, Fletcher JA (1992) Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma. Cancer Genet Cytognet 61: 193-196
169. Wernicke C, Thiel G, Lozanova T, Vogel S, Kintzel D, Janisch W, Lehmann K, Witkowski R (1995) Involvement of chromosome 22 in ependymomas. Cancer Genet Cytognet 79: 173-176
170. West C (1985) Ependymomas factors in clinical and diagnostic staging. Cancer 56: 1812-1816
171. Westermark B, Nister M (1995) Molecular genetics of human glioma. Curr Op Oncol 7 220-225
172. Wold WS, Mackey JK, Brackmann KH, Takemori N, Rigden P, Green M (1978) Analysis of human tumors and human malignant cell lines for BK virus-specific DNA sequences Proc Natl Acad Sci USA 75: 454-458
173. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B (1987) Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84: 6899-6903
174. Wu JK, Chikaraishi DM (1990) Differential expression of mos oncogene in primary human astrocytomas and astrocytoma cell lines. Cancer Res 50: 3032-3035
175. Wullich B, Muller HW, Fischer U, Zang KD, Meese E (1993) Amplified met gene linked to double minutes in human ghoblastoma. Bur J Cancer 29A: 1991-1995
176. Wullich B, Sattler HP, Fischer U, Meese E (1994) Two independent amplification events on chromosome 7 in glioma: amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET. Anticancer Res 14: 577-579
177. Zagzag D, Miller DC, Sato Y, Rifkin DB, Burstein DE (1990) Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res 50: 7393-7398